drugset / Trial / NCT01261117

Efficacy and Safety of Oral Versus Intravenous Ibuprofen for PDA Treatment in ELBW Infants

NCT01261117 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

To determine whether oral or intravenous ibuprofen has a better or same efficacy and tolerance in closure of patent ductus arteriosis in extremely-low-birth-weight preterm infants.

Timeline

Start
2009-01
Primary completion
2011-04
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibuprofen Small molecule 5 mg/kg Oral